Despite effective vaccines, diphtheria (D) resurged recently in the former socialistic block, and tetanus (T) still occurs in less privileged... Context • Current treatment options offer only symptomatic pain relief for patients with osteoarthritis (OA). Thus, a need exists for...
Diphtheria and Tetanus Antibody Persistence in Ind...
Efficacy of an Ayurvedic Formulation for Mild-to-m...
Med indite Communications is established to fill a gap of technical expertise and medical knowledge for transformative outcomes in clinical research for betterment of patients. As a ‘specialized’ service provider we provide a higher level of scientific engagement, medical expertise and value to our clients through thought leadership, deep domain knowledge, and scientifically focus approach. Our focus has always been on partnering and working closely with each client to build scientifically robust concept to achieve better outcome, increase operational efficiencies and ensure consistent regulatory compliance.
Med Indite Communications has created a cost and resource-optimized business model, affording them the flexibility and scalability to tap into a talent with a diverse skill-set. The firm is a service provider for the biotech generic pharmaceutical, medical device and contract research industry in the areas of clinical development, safety & risk management, regulatory affairs and scientific writing services.
“Indite Communication's editing dramatically improved my manuscript. They have an excellent writer team who sharpened my prose. The team is also fluent in medicine and statistics. Because of that, they are able to understand and help improve the manuscript."
"Indite Communications has shown great flexibility and expertise in medical writing and beyond....has continuously demonstrated strong writing and biostatistics skills, and has a great ability to step in quickly and efficiently.”
".......wrote several clinical study reports for us and we would not hesitate to hire their services again. The work they produced was of high quality, delivered on time and they were easy to work with.”
Statistical analyses
Clinical Study Protocols
Clinical Study
Manuscripts
Publications
Conference Posters/abstracts
Check point inhibitors, such as anti- programmed death 1 (PD-1) (Nivolumab, Pembrolizumab)/ anti-programmed death-ligand 1 (PD-L1) therapies (Atezolizumab, Avelumab and Durvalumab) have dramatically changed the therapeutic and pro...
Accelerated approval to Polivy (Polatuzumab vedotin), in combination with the chemotherapy bendamustine and rituximab (P-BR) by the U.S. FDA for the treatment of patients with relapsed or refractory diffuse large B cell lymphoma (...
Recommendations of an Oncology Drugs Advisory Committee (ODAC) against approval of Quizartinib further opened debate on effective end point for registration studies of acute myeloid leukemia (AML). Though, the Study AC220-007 show...
Eboigbodin K.E. et al., Diagnostic Microbiology and Infectious Disease, 2016 Recent worldwide large outbursts of the ZIKV necessitate the availability of a rapid, cost-effective and quick diagnostic method for ZIKV detection. Conv...
Salje H. et al., PNAS, 2016 Contraction of the disease during an infectious disease epidemic is dependent on interrelated factors, that may be directly related to the individual (age, sex), his family or the wider community of whi...
Lebel C. et al., Biological Psychiatry, 2016 It is well- known that perinatal maternal depression is a serious health concern, with its negative effects lasting on children. Prenatal depression is associated with altered br...
Marso S.P. et al., NEJM 2016 In order to fulfil regulatory requirement of establishing cardiovascular safety of new diabetes therapies in patients with type 2 diabetes a non inferiority trial as compared to placebo was plan...
Zhang P. et al., 2017, The Lancet Utidelone, a genetically engineered epothilone analogue, has emerged as a potential treatment for breast cancer in phase 1 and 2 trials. This phase III multicentre, open- label, randomized ...
Pradeep A. R. et al, November 2016, Journal of Periodontology Gingivitis, the early stage of periodontal disease, is an infection of the tissues that surround your teeth, and is caused by a buildup of plaque.Anant...
Pradeep A. R. et al, November 2016, Journal of Periodontology Since the discovery of antibiotics in the 1940s, research in this domain has been continuous, giving the world of an array of antibiotics. However, developm...
Ling L. et al, 2015, Nature Since the discovery of antibiotics in the 1940s, research in this domain has been continuous, giving the world of an array of antibiotics. However, development of resistance to these antibiotics ...
Mosquirix(RTS,S/ AS01) is a protein- based recombinant malaria vaccine, recently approved by the EMA. It is the first licensed vaccine, to be used for a parasitic disease. Developed by GlaxoSmithKline Vaccines, Belgium, in ...
Thabit H. et al., Lancet Diabetes Endocrinology, 2017 An open- label, parallel- group, randomized controlled trial was conducted by Thabit H et al. to assess the safety and efficacy of fully closed-loop insulin d...
